Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine.
about
Long-term opioid management for chronic noncancer painNovel Drug Delivery Systems.Medical cost impact of intrathecal drug delivery for noncancer pain.Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study.Implantable intrathecal pumps for chronic pain: highlights and updates.Characteristics of distribution of morphine and metabolites in cerebrospinal fluid and plasma with chronic intrathecal morphine infusion in humansRole of pretrial systemic opioid requirements, intrathecal trial dose, and non-psychological factors as predictors of outcome for intrathecal pump therapy: one clinician's experience with lumbar postlaminectomy pain.Intrathecal drug delivery system (IDDS) for cancer pain management: a review and updates.Intrathecal bupivacaine for chronic pain: a review of current knowledge.Complications of intrathecal drug delivery systems.Intraspinal therapy for the treatment of chronic pain: a review of the literature between 1990 and 2005 and suggested protocol for its rational and safe use.A history of intraspinal analgesia, a small and personal journey.Interventional therapies for chronic low back pain.The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.Combined epidural morphine and bupivacaine in the treatment of lumbosacral radicular neuropathic pain: a noncontrolled prospective studyContinuous morphine infusion: a retrospective study of efficacy, safety, and demographic variables.Implantable intrathecal pumps for the treatment of noncancer chronic pain in elderly population: drug dose and clinical efficacy.The management of pain from collapse of osteoporotic vertebrae with continuous intrathecal morphine infusion.A Prospective, Randomized Trial of Intrathecal Injection vs. Epidural Infusion in the Selection of Patients for Continuous Intrathecal Opioid Therapy.Long-term intrathecal ziconotide therapy: a case study and discussion.Methadone in the intrathecal treatment of chronic nonmalignant pain resistant to other neuroaxial agents: the first experience.Cost effectiveness of intrathecal therapy for pain.Intrathecal opioid therapy for pain: efficacy and outcomes.Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management.A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.Future trends in the development of local drug delivery systems: intraspinal, intracerebral, and intraparenchymal therapies.Efficacy and Safety of Intrathecal Opioid/Bupivacaine Mixture in Chronic Nonmalignant Pain: A Double Blind, Randomized, Crossover, Multicenter Study by the National Forum of Independent Pain Clinicians (NFIPC).Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management.Cost impact of intrathecal polyanalgesia.Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study.Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations.Alternative intrathecal agents for the treatment of pain.Preclinical Toxicity Study of Intrathecal Administration of the Pain Relievers Dextrorphan, Dextromethorphan, and Memantine in the Sheep Model
P2860
Q24240811-BE815668-BADD-4D44-86B0-F3F09FA4CD4FQ34040441-2ADC3723-C583-4F6A-8E5B-417CFFE06261Q34332318-3FEB8876-0CB7-46CB-9A9E-486DA17D0DB6Q35752995-D0014EF0-40FD-4A71-9B9F-A9975A057919Q36147968-1E387315-E6D0-4916-8E74-9AD0D5BE6C9FQ36275590-528AA134-D9FC-4AA6-9646-4A173D225A71Q37944866-71A53D8F-7305-4390-9274-C78633C6F908Q37956953-B34BB267-3ABD-4856-8E15-E0FA1E9C8CBAQ37965863-8DE2680A-A901-413E-8BDC-3DB3F8A3129AQ37965967-F68C0EC7-58C5-47CA-B94C-8E41AA9F8B1EQ37965981-E30FAFB6-CA33-4BD4-B45F-809635184184Q37996441-2E7D4F89-2F1B-4687-A5FC-87343249BF91Q38268035-30617057-1D99-48CD-8C87-E0C8309FFCD8Q38727834-81E48ACB-57BE-46E9-BC75-4590761B6534Q39163016-6EDAFC48-8929-4B46-94BF-3AD269D0E94AQ39305666-4F15B4EC-77A6-4708-9A01-B76F8E6BDE7BQ39325616-EE8E2D20-1D0D-4D2D-BE6C-C6C64366900BQ39337548-5143E6D6-6921-4429-840B-E2751D3B85D2Q39393331-ADA5C1A3-E545-4F6C-BF3A-AAA555F313C5Q39417342-5BDE2803-1B04-4748-9C8A-895BBDA5CD26Q39423649-DD697D65-A002-42EF-8184-B5FD63E7EB3FQ39440481-5E07C9CC-7272-4A4D-B5A4-D8B0F37120EBQ39440489-98A35889-B214-4626-917B-EE0D41C409F1Q39440496-8A5CC54D-3536-4805-A08D-7DB788EE1953Q39441808-0C97BADB-AC23-4ED5-8168-F6F8A60D16D3Q40819496-EE8B9A91-5473-4C49-A467-FA2D8FD69261Q42723086-C2F1EA9D-ECE2-4DEC-BFB3-A61F67313218Q43645608-426B62AF-D524-46BB-9D1E-4A4CB5DFECF9Q43763677-C4A40BA1-7486-47F5-B53D-22611D54665FQ46155536-A80BEAA1-3164-4F75-942A-D449AE60DF2CQ47238797-5905B1B2-6333-44A6-9AE1-A00601510A09Q51468178-E183237D-DFD6-4ACE-9431-F5CDEF528119Q57499145-B528C3FF-742F-4A13-9A8C-692D1E768FAD
P2860
Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Intrathecal infusional analges ...... d with or without bupivacaine.
@en
Intrathecal infusional analges ...... d with or without bupivacaine.
@nl
type
label
Intrathecal infusional analges ...... d with or without bupivacaine.
@en
Intrathecal infusional analges ...... d with or without bupivacaine.
@nl
prefLabel
Intrathecal infusional analges ...... d with or without bupivacaine.
@en
Intrathecal infusional analges ...... d with or without bupivacaine.
@nl
P1476
Intrathecal infusional analges ...... d with or without bupivacaine.
@en
P2093
E S Krames
R M Lanning
P304
P356
10.1016/0885-3924(93)90083-8
P577
1993-11-01T00:00:00Z